These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30447406)

  • 1. A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?
    Hutchison SM; Mâsse LC; Brain U; Oberlander TF
    Early Hum Dev; 2019 Jan; 128():21-26. PubMed ID: 30447406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
    JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models.
    Hutchison SM; Mâsse LC; Pawluski JL; Oberlander TF
    Reprod Toxicol; 2021 Jan; 99():80-95. PubMed ID: 33253794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH
    Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years.
    Hutchison SM; Mâsse LC; Glier MB; Brain U; Devlin AM; Oberlander TF
    J Dev Behav Pediatr; 2019 May; 40(4):266-274. PubMed ID: 30950906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence.
    Koc D; El Marroun H; Stricker BH; Muetzel RL; Tiemeier H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Feb; 9(2):217-226. PubMed ID: 37926188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
    El Marroun H; White TJ; Fernandez G; Jaddoe VW; Verhulst FC; Stricker BH; Tiemeier H
    J Psychopharmacol; 2017 Mar; 31(3):346-355. PubMed ID: 27624153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
    Oberlander TF; Reebye P; Misri S; Papsdorf M; Kim J; Grunau RE
    Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
    Handal M; Skurtveit S; Furu K; Hernandez-Diaz S; Skovlund E; Nystad W; Selmer R
    BJOG; 2016 Nov; 123(12):1908-1917. PubMed ID: 26374234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.
    Hutchison SM; Brain U; Grunau RE; Kuzeljevic B; Irvine M; Mâsse LC; Oberlander TF
    BJPsych Open; 2023 Feb; 9(2):e26. PubMed ID: 36721917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
    Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
    Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.